
China Resources Boya Bio-pharmaceutical Group Investor Relations Material
Latest events

Q1 2025
25 Apr, 2025

H2 2024
19 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from China Resources Boya Bio-pharmaceutical Group Co Ltd
Access all reports
China Resources Boya Bio-pharmaceutical Group Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and distribution of plasma-derived biopharmaceutical products. The company's offerings include a range of products for immune system support, blood coagulation, and other therapeutic uses. China Resources Boya operates production facilities and leverages advanced bioprocessing technologies to ensure high standards in the manufacturing and quality control of its products. In addition to its focus on healthcare needs, the company also engages in initiatives aimed at expanding its biopharmaceutical pipeline. China Resources Boya Bio-pharmaceutical Group is headquartered in Chengdu, China, and its shares are listed on the Shenzhen Stock Exchange.
Key slides for China Resources Boya Bio-pharmaceutical Group Co Ltd


H1 2024
China Resources Boya Bio-pharmaceutical Group Co Ltd


H1 2024
China Resources Boya Bio-pharmaceutical Group Co Ltd
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
300294
Country
🇨🇳 China